TrialEuropean child & adolescent psychiatry2025

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study.

Celso Arango et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.